electroCore, Inc. (ECOR)
NASDAQ: ECOR · Real-Time Price · USD
7.55
+0.96 (14.57%)
Apr 24, 2025, 4:00 PM EDT - Market closed
electroCore Revenue
In the year 2024, electroCore had annual revenue of $25.18M with 57.09% growth. electroCore had revenue of $7.05M in the quarter ending December 31, 2024, with 35.73% growth.
Revenue (ttm)
$25.18M
Revenue Growth
+57.09%
P/S Ratio
2.24
Revenue / Employee
$344,959
Employees
73
Market Cap
54.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25.18M | 9.15M | 57.09% |
Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ECOR News
- 7 days ago - gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries - GlobeNewsWire
- 8 days ago - electroCore to Participate at the Planet MicroCap Showcase - GlobeNewsWire
- 21 days ago - electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times - GlobeNewsWire
- 23 days ago - electroCore to Participate at the Needham Virtual Healthcare Conference - GlobeNewsWire
- 24 days ago - electroCore Extends VA Contract for Five Years - GlobeNewsWire
- 6 weeks ago - electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - electroCore Announces Full Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025 - GlobeNewsWire